Regional health priorities for dementia: a roadmap for the Western Pacific
- PMID: 39399866
- PMCID: PMC11471056
- DOI: 10.1016/j.lanwpc.2024.101179
Regional health priorities for dementia: a roadmap for the Western Pacific
Abstract
In the Western Pacific Region, the prevalence of dementia is expected to increase, however, the diversity of the region is expected to present unique challenges. The region has varying levels of preparedness, with a limited number of countries having a specific national dementia plan and awareness campaigns. Diversity of risk and healthcare services within the region is exerting impact on diagnosis, treatment, care, and support, with most countries being under resourced. Similarly, the ability to monitor dementia-related indicators and progress research, particularly relating to treatment and clinical trial access needs to be addressed. Countries require comprehensive national plans that lay out how resources will be allocated to improve dementia literacy, train, and support carers, mobilise resources to reduce risk factors and improve research capabilities. These plans need to be informed by consumers and tailored to the region to develop an inclusive society for people living with dementia and their families.
Keywords: Alzheimer’s disease; Dementia; Health policy; Western pacific region.
© 2024 The Authors.
Conflict of interest statement
ST's research is supported by an NHMRC Ideas Grant (APP2029871), FightMND, and Lenity Australia. SHK was supported by a grant of the Korea Dementia Research Project through the Korea Dementia Research Center (KDRC), funded by the Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea (RS-2024-00348451)”. SW is the Clinical Lead/steering committee co-chair of the ADNeT Registry and received an honorium from ROCHE and Eisai for attendance at an advisory meeting. KJA received a speaker honorarium from Roche in 2023 and is supported by ARC FL19010001. CO is supported by a University of Sydney Robinson Fellowship and an Australian National Health and Medical Research Council EL2 Fellowship (2016866). CSYL is supported by the Sydney Medical School Foundation, University of Sydney. DF is supported by the Edwards Fund for Dementia Research and has received research grants from the Dementia Australia Research Foundation, outside the work submitted. OP is supported in part by an NHMRC Leadership Fellowship and has received research grants from the NHMRC and the Australian Research Council, outside the submitted work. JCM received a speaker honorarium; investigator-initiated research grant to institution from Eisai Australia. Y-HJ has received research grants from the National Health and Medical Research Council (NHMRC) and Arcare in Australia and travel support for invited talks from Singapore Sing Health, Northern Ireland Queen’s University Belfast, Hong Kong Jockey Club, and Korea National Health Insurance Service: Long-term Care, all outside the submitted work. MCK was supported by a NHMRC Practitioner Fellowship (1156093) and National Health and Medical Research Council of Australia Partnership Project (1153439). RHT is supported by a FightMND Mid-Career Fellowship and her research is supported by NSW Health and MNDRA. GS is supported by the Japan Agency for Medical Research and Development. SN received a speaker honorarium HT, SP, DT, SM, SA, VCTM, NS, JYS, have no conflict of interests to declare.
Figures

References
-
- The World Health Organization . 2017. Global action plan on the public health response to dementia 2017–2025. Geneva.
-
- The World Health Organization . 2021. Global status report on the public health response to dementia. Geneva.
-
- The Australian Department of Health . Department of Health, Australian Government; 2015. National framework for action on dementia 2015–2019.
-
- The New Zealand Ministry of Health . Ministry of Health; New Zealand: 2013. New Zealand framework for dementia care.
Publication types
LinkOut - more resources
Full Text Sources